Discounted Cash Flow

Orthofix Medical Inc.

OFIX · Based on 10 years of SEC filings

DCF estimate unavailable — only_4_profitable_out_of_10

Average annual growth rates

Metric 10-Year 5-Year 3-Year
Sales
Free Cash Flow
Average (FCF & NI)
Net Income

Average annual growth is the mean year-over-year change across each period.

Endpoint CAGR (better for long term trend)

Metric 10-Year 5-Year 3-Year
Sales
Free Cash Flow
Average (FCF & NI)
Net Income

Endpoint CAGR is the compound annual rate from the first to last year in each period.

Projections use average year-over-year growth. Change this in Settings.

Projected growth rate

Free cash flow growth
10-year: — 5-year: — 3-year: —
Averaged growth (FCF & NI)
10-year: — 5-year: — 3-year: —
Net income growth
10-year: — 5-year: — 3-year: —
Sales growth (not added to calculations)
10-year: — 5-year: — 3-year: —

Click a greyed-out slider to switch metrics. Slide between the 10-year, 5-year, and 3-year historic growth rates for FCF, net income, or their average.

%
%

Historical inputs (10 fiscal years)

YEAR Sales Net Income Free Cash Flow Net Margin EPS (diluted)
2016 $409.8m $3.1m $28.3m 0.7% $0.17
2017 $433.8m (5.9%) $6.2m (103.6%) $38.7m (36.8%) 1.4% (92.4%) $0.34 (100.0%)
2018 $453.0m (4.4%) $13.8m (121.9%) $36.3m (-6.1%) 3.0% (112.5%) $0.73 (114.7%)
2019 $460.0m (1.5%) $-28.5m (-306.1%) $13.0m (-64.1%) -6.2% (-303.0%) $-1.51 (-306.8%)
2020 $406.6m (-11.6%) $2.5m (108.8%) $58.8m (351.0%) 0.6% (110.0%) $0.13 (108.6%)
2021 $464.5m (14.2%) $-38.4m (-1624.8%) $690.0k (-98.8%) -8.3% (-1434.7%) $-1.95 (-1600.0%)
2022 $460.7m (-0.8%) $-19.7m (48.5%) $-32.9m (-4868.4%) -4.3% (48.1%) $-0.98 (49.7%)
2023 $746.6m (62.1%) $-151.4m (-666.6%) $-106.0m (-222.2%) -20.3% (-373.0%) $-4.12 (-320.4%)
2024 $799.5m (7.1%) $-126.0m (16.8%) $-9.1m (91.4%) -15.8% (22.3%) $-3.30 (19.9%)
2025 $822.3m (2.9%) $-92.2m (26.8%) $-1.3m (85.9%) -11.2% (28.9%) $-2.33 (29.4%)

Base FCF: (latest fiscal year)

Discount rate: %

Terminal growth:

Projection period: years

Alt A decline yrs:

Alt B total yrs:

Projected cash flows

Year Projected cash flow Discount Factor Present Value

PV of projected FCF:

Terminal FCF:

Terminal value:

PV of terminal value:

Enterprise value (DCF):

DCF price per share:

Current price:

Alternative DCF Models

Model Fair Value Upside PV(FCFs) PV(Terminal) Total Years
Standard (10yr→TV) 10 + TV
Alt A (Gradual Decline)
Alt B (30yr Hard Stop) N/A

This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.

+ 10YR Financials Balance Sheet (10YR) Cash Flow (10YR) DCF Model

only_4_profitable_out_of_10

Once the company meets all DCF eligibility criteria (sufficient history, profitability, growth trends), an estimate will become available automatically. No action is needed.